Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to step aside by the board following an investigation into suspected illegal activity by Chinese customs.

SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday ...

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other ...

Legend Biotech Corporation 29.21 + 0.55% Summary News Research Chart Community Statistics Historical Data Profile Financials Analysis Options Holders Sustainability NasdaqGS - Nasdaq Real Time ...

Johnson & Johnson and Legend Biotech’s BCMA-targeted CAR-T therapy Carvykti has been approved by the FDA to treat patients with multiple myeloma after at least one prior therapy. The decision ...

1 Day LEGN 4.79% DJIA 0.32% S&P 500 0.09% Health Care/Life Sciences -0.79% ...

STAT Plus: ‘We are all terrified’: Mass General Brigham to lose millions in medical research grants under Trump cuts ...